Germany's Merck KGaA said on Thursday it is in late-stage talks to acquire U.S.-based SpringWorks Therapeutics for about $3.5 ...

Merck maintained its 2025 full-year revenue guidance of $64.1 billion to $65.6 billion, representing 1% to 3% growth excluding foreign exchange impacts. EPS guidance was adjusted to $8.82 to $8.97, ...

However, while negotiations with South Korea progressed, the US and China continued to be at odds ... For the full year, Merck (MRK) lowered its earnings outlook slightly, citing an estimated ...